143 results have been found
February 26, 2021
Grifols increases its revenues to 5,340 M€ and continues to demonstrate its resilience and commitment to sustainable growth
January 27, 2021
Grifols is included in the Bloomberg Gender-Equality Index for its commitment to gender equality
January 22, 2021
Japan’s regulator approves Grifols’ Lynspad™ [alpha-1 proteinase inhibitor] for the treatment of alpha-1 antitrypsin deficiency
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?